chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Horrific joint pain; Couldn't lift arms, use wrists for 1 week after first shot; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine; lot number EN6200 and expiration date: not reported), via an unspecified route of administration, in Left Arm, on 19Feb2021 (at the age of 64-year-old) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history included Multiple sclerosis, mast cell disorder, gluten allergy, and Autoimmune disorder. The patient was not pregnant at the time of vaccination. Concomitant medications included topiramate (TOPAMAX), alfuzosin, methylphenidate hydrochloride (RITALIN), cromolyn (cromoglicic acid), and levothyroxine sodium (SYNTHROID). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 20FEB2021, after first shot the Patient experienced Horrific joint pain and couldn't lift arms, used wrists for 1 week. No treatment was received for the adverse event. The outcome of the events was recovering at time of report.   No follow-up attempts are needed. No further information is expected
and 09Mar diagnosed with pneumonia, caller was released from hospital on 24Mar; COVID 04Mar, and 09Mar diagnosed with pneumonia, caller was released from hospital on 24Mar; This is a spontaneous report from a contactable consumer (patient). A female patient of unknown age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection),via an unspecified route of administration on 27Feb2021 as single dose for COVID-19 immunisation. The patient medical history was none. The concomitant medications were not reported. Patient received first dose 27Feb2021. Diagnosed with COVID 04Mar2021, and 09Mar2021 diagnosed with pneumonia, she was released from hospital on 24Mar2021. Caller would like to know if she can get the second dose of vaccine. The patient outcome for the events was unknown.   Information on the lot/batch number has been requested.   Follow-up attempts were completed. No further information was expected.
Patient came in for her Pfizer booster #1 (already had previous Pfizer Dose 1 & 2) and I administered the Pfizer-BioNTech COVID-19 Monovalent vaccine, instead of the Bivalent Pfizer-BioNTech COVID-19 Vaccine.  The Monovalent is outdated now and I should have given the Bivalent vaccine.  NO adverse reaction occurred to patient during or after vaccination. Patient was monitored for 15min after administration of Pfizer-BioNTech COVID-19 vaccine and felt fine, asymptomatic, with no adverse reacitons/symptoms during, 15minutes, and 20 minutes after administration.
1 to 1.5yr p/vax pt recv vax & devel an inj site rxn characterized by tenderness, warmth, swelling, redness & a knot;sx resolved p/1 wk;
Both legs achy, sore back, skin sensitive Treatment: Took two Advil(200mg each), went to bed. Woke up feeling fine in the morning
I kept this on my calendar so I could remember.   07/29/2022 - 07/31/22:  sore throat, Fever, chills, body aches 08/01/2022:  sore throat, Fever, chills, body aches PLUS nasal congestion and headache. 08/02/2022 - 08/03/2022:  body aches, nasal congestion, headache that got worse 08/03/2022 -08/05/2022:  moved down into my chest with heavy coughing, headache, nasal congestion. 08/05/2022:  coughing and alot of nasal congestion with muffled hearing, ringing and PAIN mainly in right ear.  08/08/2022:  Went to doctor because ears and head were hurting so bad.  Prescribed amoxicillian.   08/13/2022:  right ear is still sore, muffled and ringing.  Still have some nasal and chest congestion.   I was not sick at all or around anyone sick prior to vaccine.  No one around me has gotten sick being around me.  This illness has had me down since 07/29/2022.   I wasnt this sick when I had COVID a couple years ago.   Also, I tested negative for COVID and flu on 08/08/2022 at doctors office.
Isolated Bell's Palsy occurred 10 days after patient received Menactra.  Patient also had positive Lyme titers, drawn with this episode.
Had only a sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 8-APR-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingles vaccine and had only a sore arm from the shot. Additional supportive information: The follow-up would not possible, as no contact details were available.
Information has been received from a physician concerning a patient who was vaccinated with a dose of MMR II. Subsequently the patient experienced a bad case of encephalitis. Unspecified medical attention was sought. There was no product quality complaint. Upon internal review, encephalitis was considered to be an other important medical event. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/30/2008.   No further information was available.
Patients received an expired dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Vial initial storage date in refrigerator was 08-Nov-2021. Vials did not undergo any temperature excursion.  No concomitant medication was reported by reporter. No treatment medication was reported by reporter.
2/25- stated fatigue and HA. 2/26 am elevated temp 102.8, body aches, chills, mild diarrhea,severe weakness and generalized pain.
Information has been received from a woman in a medical office concerning a 36 month old female patient who on 4/11/02 was vaccinated SC in the left thigh with a first dose of varicella virus vaccine live (lot # 641267/1294L). On 4/22/04, the patient developed chicken pox. Medical attention was not sought. Subsequently, the patient recovered. The reporter also mentioned five other patients who developed chicken pox post vaccination with varicella virus vaccine live (WAES0407USA00537, 0407USA00539, 0407USA00540, 0407USA00544, and 0407USA00548). Additional information is not expected.
Numbness and tingling in hands and feet. Loss of balance, coordination and strength in legs and feet. Difficulty sleeping, concentrating, urinating, and extreme fatigue. Nerve issues. Slowed reflexes.
pt recv vax 20JUN95 but it was not clear whether pt again exp the numbness or tingling;
Guillain-Barre syndrome; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 2021SA407150 (Manufacturer report number).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), outcome "unknown", described as "Guillain-Barre syndrome". This case involved an adult male patient who experienced guillan-barre (Guillain-Barre syndrome) while being treated with product nos and Tozinameran (Pfizer BioNTech covid-19 vaccine). On an unknown date, the patient started treatment with product nos (not otherwise specified) of unknown formulation at dosage unknown (with an unknown batch number and expiry date) and Pfizer BioNTech covid-19 vaccine (Tozinameran) of unknown formulation at dosage unknown (with an unknown batch number and expiry date) for Prophylactic vaccination. On an unknown date and unknown latency after initiation of suspect drug the patient developed guillan-barre (Guillain-Barre syndrome). This event Guillain-Barre syndrome was assessed as medically significant as per reporter. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was unknown for the event. No further information was reported.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporte (Other HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Sep2022 as dose 5 (booster), single (Lot number: GH9702) at the age of 75 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 29Jan2021 as dose 1, single (Lot number: EL9262), in right arm, on 20Feb2021 as dose 2, single (Lot number: EN6203), in right arm, on 21Oct2021 as dose 3 (booster), single (Lot number: EW0172), in right arm and on 13Apr2022 as dose 4 (booster), single (Lot number: FK9893), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer survivor" (unspecified if ongoing); "reoccurring diarrhea" (unspecified if ongoing); "reoccurring arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Mastic, reaction(s): "Reaction: Allergy", notes: known allergies Mastic. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19, vaccination failure: Paxlovid.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded.
The patient received dose from vial beyond 30 day use by date; he patient received dose from vial beyond 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose from vial beyond 30 day use by date) and PRODUCT STORAGE ERROR (he patient received dose from vial beyond 30 day use by date) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose from vial beyond 30 day use by date) and PRODUCT STORAGE ERROR (he patient received dose from vial beyond 30 day use by date). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (The patient received dose from vial beyond 30 day use by date) and PRODUCT STORAGE ERROR (he patient received dose from vial beyond 30 day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.
3:00 pm-Top lip began tingling & then numbness set in; soon after, bottom lip had same symptoms.  5:00 pm- Top lip subsided slightly; still on bottom lip. Tingling & Numbness moved to tongue til 7:00 pm.   7:30 pm -Chills & body aches began.  10:30 pm- Lymph nodes swollen. 12:15 pm-Tingling & Numbness returned to lips & tongue ( not as severe as  earlier).
I started having this feeling like my throat was swollen, almost like someone had their hand on my throat, and around about the same time I was having watery eyes, runny nose, and drainage at night. I looked at my tonsils, where I've never been able to see before, they were inflamed and my throat was red. I didn't have any pain, just the feeling of pressure on neck. I didn't think anything of it until it started occurring more frequently. I made appt with doctor  who performed mono test and strep test, both negative. She believed it was allergy related because we've had a lot of wind here recently. Although i've experienced allergies every year, i've never had issues with my throat. She prescribed zyrtec d, flonase, and benadryl and told me to take those daily until they went away. That was last week (5/18/22). The symptoms are fine in the morning time, I'm in an enclosed room with a purifier. Its throughout the day when I'm out and about that my throat feels like its starting to swell, which has continued with the medication. She said it might continue for a while and advised that once symptoms have receded to continue to take zyrtec D at night before bed.
Initial report received on 27 September 2013 f4rom a health care professional. A 75-year-old male patient, whose medical history and concomitant medications were not reported, received a dose of FLUZONE HD (lot number U4781AA, expiration date 25-May-2014 and site of vaccination was not reported) intramuscularly on 24 Sep 2013. It was reported that a 75-year-old male patient have received the FLUZONE HD. On 25-Sep-2013, patient developed a red area at injection site which has been getting larger and is now up to 4 inches across. List of documents held by sender: none
This case was reported by a physician via sales rep and described the occurrence of myalgia in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced myalgia. On an unknown date, the outcome of the myalgia was not recovered/not resolved. The reporter considered the myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The patient received a SHINGRIX vaccine at a pharmacy. The patient experienced myalgia and weeks later, still felt myalgia. To his knowledge, her symptoms had not resolved. The physician reported this patient's experience to VAERS. The physician does think her symptoms are due to the SHINGRIX injection.
Unusual tiredness, general malaise, and loose stools (after 36 hrs). At site of injection: raised, hard, sore, warm to the touch and bright red in a 1 1/2in radius around site.
pt recv vax;mom reports pt feeling bad w/ low grade T 99 & gen did not feel good;by friday mom noticed arm red & sore & site feverish;tx w/ ice packs & ibuprofen;pt better but soreness in arm & redness still present;
felt intially flu-like 9/12/p.m. 9/13 a.m. 9.00 could no longer walk 103 degrees F fever, chills/shaking very sore joints, dizzy disoriented, went to Dr with husband 3pm,;  WBC 22000 ringing in ears 9-2 (approx) migraine 10-4 pm WBC dropped 500 on 9/14 so I didn't have to go to hospital.
4 seizures were documented and EMS and 911 was called, O2 given by nasal cannula
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly male patient who received SHINGRIX for prophylaxis. The patient's past medical history included prostate cancer, neck surgery and wrist surgery. In November 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In November 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain, shivering and tremor. The patient was treated with TYLENOL. In November 2018, the outcome of the shivering and tremor were recovered/resolved. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain, shivering and tremor to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported however; the patient could be 85 or 86 years old. The patient stated that, he received SHINGRIX vaccine on left arm approximately 3 weeks before the date of reporting. The evening of getting the vaccine he experienced pain in the area of the injection site and upper arm to the shoulder. It was the most intense pain due to which he was not able to sleep. The afternoon of the second day he took TYLENOL and he took 2 doses of TYLENOL again on the third day. The pain lasted for total of 3 days. The first night he also experienced shivering and shaking that lasted all night and he recovered by morning. Once in a while the patient gets a surge of intense pain that goes through the area of injection site which goes away quickly. The reporter gave consent to follow up. The contact of physician was provided.
Severe chills, mild fever (100.0). Lasted for a few hours. Took Tylenol and helped. Fever broke next night.
Patient came in to the pharmacy to describe some of the side effects he experienced after receiving the SHINGRIX shot. He stated that approximately 24 hours after the shot, he was extremely fatigued but has improved since. He had also developed a rash which he noticed after he removed his band-aid 24 hours after the shot was initially administered. The rash appeared as of his visit on 2/12/18 at approximately 3:00 pm to be light-medium pink in color and approximately 3 to 4 inches in diameter.  He stated that it was slightly warm and slightly painful. He stated that he does not have a fever and is otherwise fine. Patient was recommended to continue observing the rash to see if it spreads or gets more warm or painful or intolerable, and if so he was instructed to inform his primary care physician.
Information has been received from a 66 year old male patient with high cholesterol and a history of quadruple vessel bypass graft in 1990, shingles and a drug reaction to CODEINE (unspecified) who on 05-JAN-2009 was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Concomitant therapy included METOPROLOL TARTRATE, ENALAPRIL MALEATE, EZETIMIBE (MSD) and LIPITOR.  On 06-JAN-2009 the patient experienced pain/ tenderness on the left side of his lower back that is just above his belt line and right above his behind.  The consumer reported that his was having pain when moving in any direction and nasty discomfort in his left heel to the point that it was starting to be painful to walk, he stated that it felt like a heel spur.  The patient was taking ibuprofen (manufacturer unknown) which had masked some of the pain.  He did not seek medical attention.  The patient's pain/tenderness on the left side of his lower back and pain when moving in any direction and nasty discomfort in his left heel that is painful to walk persisted.  No further information is available.
I experienced flu-like symptoms (chills, fever, aches, fatigue, and nausea) and a very sore arm (vaccinated arm) after receiving 2nd dose that started about 12 hours after. Took Tylenol and left over Zofran for treatment. All symptoms resolved by 48 hours post-vaccination.  I also had a rash in the vaccinated arm but about 2 inches below vaccination spot that occurred a week after receiving the 2nd dose. Resolved in 2 days.
nausea, vomiting, extreme tiredness, unable to stand, passing out, extreme muscle aching and headaches. All within 12 hours of vaccine being administered. Day three still in bed with nausea and muscle fatigue. unable to stand for longer than a few minutes without having to go back to bed and lie down again.
Patient received Covid vaccine, had sudden onset of flushed feeling, nausea no emesis, "dizzy/Fuzzy head" feeling.  Hypertensive at time BP left arm 171/95 HR 79, RR 26, 99% RA.  Apple juice, and cracker provided, and emesis bag provided.  Patient was already waiting for thirty minutes time (she was 15 minutes into her wait time).  She reported having a progression of nausea and dizziness Repeat vital signs at 1345 139/100 HR 76, RR 24 Pox 96% RA.  First responder was called and patient was assisted into wheelchair and taken to the ER for further evaluation.
This 65 year-old female patient received for immunization a single dose of PREVNAR 13 (lot M05077) intramuscular in the left deltoid on 30Aug2016 and an unspecified flu shot in the right deltoid on an unspecified date.  The patient medical history was not reported.  There were no concomitant medications. It was reported pneumococcal 13-val conj vac (dipht crm197 protein) was administered in an unusual manner: the administrator (a medical assistant) put the needle into the deltoid muscle in the left arm of the patient and with the open palm of the hand slammed the plunger into the arm. The medical assistant did not wipe the area of the injection with alcohol and did not put a Band-Aid on it after the injection. It was also reported that the vaccine suspension was pale yellow in color and it looked like a lot of stuff. On 30Aug2016 the patient experienced fatigue, aching in her left deltoid where received the injection, she had mild headache, aching all over and she had joints and bone pain, pain, trouble in falling asleep because it was uncomfortable. It was reported that when, after the vaccination, the patient went home, she was overwhelmed by significant fatigue and also had aching in her left deltoid where received the injection. For the next three to four days she had a mild headache, aching all over and she had joints and bone pain. It seemed like it coursed through her whole body twice over weeks. She mentioned that the pain bothered her in sleeping too. She had trouble in falling asleep because it was uncomfortable and she woke up in the early hours like 3 to 4 AM. She had informed her doctor about this and the pain was slowly getting better and it was coming and going. She underwent to two physical therapy sessions regarding this pain, she was also taking ibuprofen tablet oral 600 mg at least two per day to help with this pain and her fatigue was improving week by week. The patient underwent to shoulder X-ray to check and to make sure whether a piece of needle or anything else was there in her shoulder considering how violently she was injected, but there was no foreign body in her muscle or bones. The bone was fine and there were no signs of arthritis or anything else that could cause pain in her shoulder. The patient mentioned that she was not fully recovered; she was still getting physical therapies and she was recovering, but she still had pain. The pain was ongoing but in the last 2 weeks it has been settled just in the left deltoid area at the injection site and left shoulder.
Patient received Tdap vaccine in right arm on 8/29/07.  He developed redness on 08/31/2007. Patient was diagnosised with cellulitis and treated with Keflex.
Low grade fever, swollen and tender lymph glands in neck, under arm, groin, extreme join pain in all joints, extreme fatigue, redness and swelling in injection site (arm).    Stayed in bed for two and a half days, drank water, took Diclofenic sod every 75mg twice a day each day and otc extra strength Tylenol twice to three times a day.     Fever went away after three days, lymph glands okay after three days, most, but not all  joint pain gone after a week.  Redness at injection site gone after 8 days.  Fatigue is much better, still lingering as of today. (11 days).